Synairgen's antiviral drug effective against Kent and Indian Covid variants
Shares in respiratory drug development company Synairgen (SNG:AIM) gained 4% to 109.7p on Monday after studies showed its inhaled SNG001 drug was effective against key coronavirus variants.The studies were conducted at laboratories...
24 May 2021